On September 6, 2023 Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, reported its participation in two investor conferences in September 2023 (Press release, Citius Pharmaceuticals, SEP 6, 2023, View Source [SID1234634958]). Citius Chairman and CEO Leonard Mazur will present at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023, and at the Sidoti Small-Cap Virtual Conference on Wednesday, September 20, 2023.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Conference Details:

Presentation:

2:00 pm ET on September 11, 2023

Location:

Lotte New York Palace Hotel, New York City

Registration:

Available on the conference website.

1×1 meetings:

Requests available upon registration or by contacting Citius Investor Relations.

Webcast:

Join live.

Sidoti Conference Details:

Presentation:

2:30 pm ET on September 20, 2023

Location:

Virtual

Registration:

Available on the conference website.

1×1 meetings:

Requests available through a Sidoti representative.